Detalhe da pesquisa
1.
Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors.
J Transl Med
; 21(1): 586, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658364